The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Fast Track, 2001Generation and Analysis of Conditional Pre-Clinical Model Mutants for BNDF and GDNF Receptors
Parkinson's disease results largely from the degeneration of dopamincergic neurons in the substantia nigra pars compacta. The reason for the successive death of these neurons is not known so far...
-
Fast Track, 2001rAAV-ribozyme Mediated Parkin Knockdown as a Pre-clinical Model of Parkinson's Disease
Parkinson's disease is characterized by a series of debilitating motor abnormalities that worsen over time. The motor symptoms of Parkinson's disease are largely the result of the specific progressive...
-
Fast Track, 2001Molecular and Genetic Analysis of Parkin in the Pathogenesis of Parkinson's Disease
The ultimate goal of this proposal is to create new, more effective means of preventing, diagnosing and treating neural degeneration associated with Parkinson's disease (PD). PD is a chronic...
-
Fast Track, 2001A Gene Therapy Development for PD in Synuclein Transgenic Mice
The number of people with Parkinson's disease (PD) is increasing rapidly because life expectancy of people in developed countries continues to rise. Without a medical breakthrough the number of people...
-
Fast Track, 2001The Role of the Centromedian-Parafascicular Complex in the Origin and Pathophysiology of Parkinson's Disease
This study will explore the role of the centromedian (CM)-carafascicular (Pf) thalamic complex in the pathophysiology of Parkinson's disease. We expect to confirm in an animal a common origin in the...
-
Fast Track, 2001A Zebrafish Assay for Parkinson's Disease Drugs
We are developing an innovative model for Parkinson's disease using transgenic animals. The model is designed to rapidly screen thousands of potential small molecule drugs and to reduce the time it...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.